GO:1905782 positive regulation of phosphatidylserine exposure on apoptotic cell surface: Apoptotic Signal Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905782 describes any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on the surface of apoptotic cells.
• Phosphatidylserine exposure is a hallmark of apoptosis and is detected by Annexin V binding, which correlates with the stage of cell death.
• Positive regulation of this process amplifies the 'eat-me' signal for phagocytic clearance and can influence immune responses.
• Key regulators include Xkr8, which promotes PS exposure during apoptosis and differentiation, and CD9, which modulates calcium-stimulated PS exposure.
• The process is relevant to chronic lymphocytic leukemia, where PS exposure correlates with fludarabine-induced apoptosis, and to neutrophil apoptosis.
• Experimental approaches include flow cytometry with Annexin V, CRISPR knockout of candidate regulators, and live-cell imaging of PS dynamics.
Description
Phosphatidylserine (PS) is a phospholipid normally confined to the inner leaflet of the plasma membrane. During apoptosis, PS is externalized to the cell surface, where it serves as a recognition signal for phagocytes. The Gene Ontology term GO:1905782, positive regulation of phosphatidylserine exposure on apoptotic cell surface, encompasses any process that activates or increases the frequency, rate or extent of this externalization specifically on apoptotic cells. This term is distinct from the baseline exposure process and highlights the regulatory inputs that amplify the signal. Understanding this regulation is critical because efficient PS exposure ensures timely clearance of dying cells and prevents inflammatory or autoimmune responses. Defects in PS exposure regulation have been linked to hematological malignancies and impaired immune surveillance. Researchers studying apoptosis, cell clearance, and related diseases need reliable models to dissect the molecular players that positively regulate PS exposure. This article integrates authoritative GO data with real PubMed literature to provide a research-grade overview of GO:1905782, its mechanisms, key genes, and experimental strategies.
positive regulation of phosphatidylserine exposure on apoptotic cell surface At A Glance
| GO ID | GO:1905782 |
|---|---|
| GO term | positive regulation of phosphatidylserine exposure on apoptotic cell surface |
| Ontology | biological_process |
| Synonym | activation of externalization of phosphatidylserine; upregulation of phosphatidylserine exposure on apoptotic cell surface |
| Major function | Enhances the externalization of phosphatidylserine to the outer leaflet of the plasma membrane during apoptosis |
| Related process | Apoptotic cell clearance, immune recognition, phagocytosis |
| Detection method | Annexin V binding assay, flow cytometry |
| Key regulators | Xkr8, CD9, calcium signaling, P2X7R |
What Is GO:1905782?
GO:1905782 is a biological process term defined as any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface. In other words, it covers the positive regulatory events that enhance the appearance of phosphatidylserine on the outer leaflet of the plasma membrane of cells undergoing apoptosis. This term is a child of 'positive regulation of phosphatidylserine exposure' and is specific to the apoptotic context.
Why Is positive regulation of phosphatidylserine exposure on apoptotic cell surface Important in Cell Biology?
Positive regulation of phosphatidylserine exposure on apoptotic cell surface is essential for the efficient clearance of dying cells by phagocytes. Without proper amplification of PS exposure, apoptotic cells may persist, leading to secondary necrosis and inflammation. This process also influences immune tolerance and the resolution of inflammation. In diseases such as chronic lymphocytic leukemia, the extent of PS exposure correlates with the stage of apoptosis and response to therapy. Therefore, understanding the positive regulators of PS exposure can provide insights into disease mechanisms and therapeutic targets.
• Ensures timely phagocytic clearance of apoptotic cells, preventing inflammation.
• Serves as a marker for apoptosis detection in research and clinical settings.
• Modulates immune responses through PS-mediated signaling in dendritic cells.
• Correlates with chemotherapy-induced apoptosis in chronic lymphocytic leukemia.
• Involves calcium-dependent mechanisms that can be studied in T lymphocytes.
• Regulated by mitochondrial superoxide and P2X7R in T cells.
• Relevant to neutrophil apoptosis and loss of surface markers.
• Xkr8-mediated PS exposure is important for myoblast differentiation and survival.
• Provides targets for modulating cell death in cancer and autoimmune diseases.
• Enables experimental dissection of apoptotic pathways using Annexin V and CRISPR screens.
What Happens During positive regulation of phosphatidylserine exposure on apoptotic cell surface?
Initiation of Apoptosis and Calcium Signaling
In simple terms: When a cell receives a death signal, calcium levels rise inside the cell, which helps flip phosphatidylserine to the outside.
Apoptotic stimuli trigger intracellular calcium release, which is a key driver of phosphatidylserine (PS) exposure. In Jurkat T lymphocytes, calcium-stimulated PS exposure is regulated by CD9, a tetraspanin protein. This suggests that calcium signaling pathways positively regulate PS externalization. Additionally, mitochondrial superoxide generation can enhance P2X7R-mediated loss of CD62L and potentially influence PS exposure in T cells.
Activation of Scramblases and Phospholipid Redistribution
In simple terms: Special proteins called scramblases help move phosphatidylserine from the inner to the outer side of the membrane.
Phospholipid transverse redistribution is promoted by domain inducers such as phosphatidylinositol 4,5-bisphosphate, which can increase PS exposure in biological membranes. Xkr8 (Xk-related protein 8) is a scramblase that regulates PS exposure during apoptosis and is also involved in myoblast differentiation and survival. Positive regulation of PS exposure likely involves activation or increased activity of such scramblases.
Amplification of PS Exposure by Regulatory Proteins
In simple terms: Certain proteins can boost the amount of phosphatidylserine that appears on the cell surface.
CD9 has been shown to have a regulatory effect on calcium-stimulated PS exposure in Jurkat T lymphocytes, indicating a positive modulatory role. In chronic lymphocytic leukemia cells, PS exposure correlates with the stage of fludarabine-induced apoptosis and expression of apoptosis-regulating genes, suggesting that positive regulators are activated during chemotherapy-induced cell death. The exact mechanisms of amplification may involve feedback loops and crosstalk with other apoptotic pathways.
Recognition and Clearance by Phagocytes
In simple terms: Once phosphatidylserine is outside, it acts like an 'eat me' signal for immune cells to engulf the dying cell.
Exposed PS is recognized by phagocytes, leading to clearance of apoptotic cells. Phosphatidylserine regulates the maturation of human dendritic cells, linking PS exposure to immune modulation. In neutrophils, apoptosis leads to acquisition of Annexin V binding sites, which is a measure of PS exposure and precedes clearance. Positive regulation ensures that enough PS is exposed to trigger efficient phagocytosis.
Key Genes Involved in GO:1905782 positive regulation of phosphatidylserine exposure on apoptotic cell surface
The following genes and proteins have been experimentally linked to the regulation of phosphatidylserine exposure on apoptotic cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Xkr8 | Scramblase that promotes PS exposure during apoptosis and differentiation | Regulates myoblast differentiation and survival; potential target for muscle disorders |
| CD9 | Tetraspanin that modulates calcium-stimulated PS exposure | Regulates PS exposure in T lymphocytes; involved in immune cell apoptosis |
| P2X7R | Purine receptor that can enhance PS exposure via superoxide | Mediates loss of CD62L in T cells; links inflammation to PS exposure |
| Annexin V (ANXA5) | Binds PS with high affinity; used as a detection tool | Gold standard for measuring PS exposure by flow cytometry |
| Fas (CD95) | Death receptor that triggers apoptosis and PS exposure | Model for studying apoptosis-induced PS exposure |
| Bcl-2 | Anti-apoptotic protein; its downregulation correlates with PS exposure | Expression levels correlate with fludarabine-induced apoptosis in CLL |
| Bax | Pro-apoptotic protein; promotes mitochondrial outer membrane permeabilization | Expression correlates with PS exposure in CLL |
| Caspases | Proteases that execute apoptosis and activate scramblases | Central to apoptosis and PS exposure; targets for inhibitors |
| TMEM16F | Calcium-activated scramblase | Potential regulator of PS exposure in platelets and other cells |
| PIP2 | Phospholipid that promotes transverse redistribution | Domain inducer that enhances PS exposure |
| Dendritic cell markers (CD83, CD86) | Maturation markers influenced by PS | PS regulates dendritic cell maturation |
| CD62L (L-selectin) | Adhesion molecule lost during apoptosis | P2X7R-mediated loss correlates with PS exposure |
| FcγRIII (CD16) | Neutrophil surface receptor lost during apoptosis | Acquisition of Annexin V binding sites during apoptosis |
| Fludarabine | Chemotherapeutic that induces apoptosis in CLL | PS exposure correlates with stage of fludarabine-induced apoptosis |
| Calcium channels | Mediate calcium influx that triggers PS exposure | Calcium signaling is required for PS externalization |
How Is positive regulation of phosphatidylserine exposure on apoptotic cell surface Regulated?
The positive regulation of phosphatidylserine exposure on apoptotic cell surface is controlled by multiple signaling pathways. Calcium signaling is a primary driver, as calcium influx can stimulate PS exposure, and this process is modulated by CD9 in T lymphocytes. Mitochondrial superoxide generation can enhance P2X7R-mediated effects, linking oxidative stress to PS exposure. Phospholipid domain inducers such as phosphatidylinositol 4,5-bisphosphate promote transverse redistribution of phospholipids, thereby increasing PS exposure. Additionally, apoptotic regulators such as Bcl-2 and Bax influence the threshold for PS exposure during chemotherapy-induced apoptosis. The interplay between these pathways ensures that PS exposure is tightly regulated and amplified when needed for efficient clearance.
positive regulation of phosphatidylserine exposure on apoptotic cell surface and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Xkr8 | Myoblast differentiation and survival | Xkr8 knockout myoblasts; differentiation assays |
| CD9 | T cell apoptosis and immune regulation | CD9 knockout Jurkat T cells; calcium-induced PS exposure |
| Bcl-2 | Chronic lymphocytic leukemia | Bcl-2 overexpression in CLL cell lines; fludarabine treatment |
| P2X7R | T cell inflammation and apoptosis | P2X7R knockout T cells; superoxide measurement |
| Annexin V | Apoptosis detection in various diseases | Recombinant Annexin V for flow cytometry |
Chronic Lymphocytic Leukemia (CLL)
In CLL, cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis and expression of apoptosis-regulating genes such as Bcl-2 and Bax. Positive regulation of PS exposure may influence the efficacy of chemotherapy and the clearance of dying leukemia cells. Understanding these regulatory mechanisms could lead to improved therapeutic strategies.
Autoimmune and Inflammatory Disorders
Defective clearance of apoptotic cells can lead to autoimmunity. Phosphatidylserine exposure is critical for the recognition and engulfment of apoptotic cells by phagocytes. Positive regulators that enhance PS exposure may help prevent the accumulation of secondary necrotic cells and the release of autoantigens. Conversely, excessive PS exposure might contribute to immune suppression in tumors.
Muscle Disorders
Xkr8, a regulator of PS exposure, is involved in myoblast differentiation and survival. Dysregulation of PS exposure could affect muscle regeneration and contribute to muscle-wasting conditions. Further research is needed to link GO:1905782 specifically to muscular dystrophies.
From positive regulation of phosphatidylserine exposure on apoptotic cell surface-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate PS exposure during apoptosis? | CRISPR knockout of gene X in HeLa or Jurkat cells, followed by Annexin V staining |
| Does a point mutation in a scramblase affect PS exposure? | CRISPR point mutation knock-in of the mutation in cell lines, then flow cytometry |
| Can overexpression of a candidate gene enhance PS exposure? | CRISPR activation or lentiviral overexpression, then Annexin V assay |
| What is the role of calcium signaling in PS exposure? | Calcium chelators or channel blockers in T lymphocytes |
| Does Xkr8 regulate PS exposure in muscle cells? | Xkr8 knockout myoblasts and differentiation assays |
| How does PS exposure affect dendritic cell maturation? | PS liposomes or apoptotic cell co-culture with dendritic cells |
How to Study the positive regulation of phosphatidylserine exposure on apoptotic cell surface Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | PS exposure on cell surface | Quantifying apoptosis in cell lines and primary cells |
| Live-cell imaging | Dynamics of PS exposure | Real-time monitoring of apoptotic cells |
| CRISPR knockout screen | Identification of positive regulators | Genome-wide discovery of genes affecting PS exposure |
| CRISPR activation screen | Enhancement of PS exposure | Overexpression of candidate genes to test positive regulation |
| Phospholipid scrambling assay | Scramblase activity | Biochemical characterization of Xkr8 and other scramblases |
| Calcium imaging | Intracellular calcium levels | Linking calcium signaling to PS exposure |
| Western blot | Expression of apoptosis regulators | Correlating Bcl-2/Bax levels with PS exposure |
| Immunophenotyping | Loss of surface markers (e.g., CD62L, CD16) | Tracking apoptosis in leukocytes |
Flow Cytometry with Annexin V
Annexin V binding is the most widely used method to detect phosphatidylserine exposure on apoptotic cells. This method can be combined with propidium iodide to distinguish early and late apoptosis. It is applicable to many cell types, including B cells, T cells, and neutrophils.
Live-Cell Imaging of PS Dynamics
Fluorescently labeled Annexin V or PS-binding probes can be used for real-time imaging of PS exposure. This allows researchers to track the kinetics of positive regulation in response to stimuli. It is particularly useful for studying calcium-dependent PS exposure.
CRISPR Screens for Regulators
Genome-wide CRISPR knockout or activation screens coupled with Annexin V sorting can identify positive regulators of PS exposure. This approach can uncover novel genes involved in GO:1905782. Xkr8 was identified through such functional studies.
Biochemical Assays for Scramblase Activity
Scramblase activity can be measured using fluorescent phospholipid analogs in membrane preparations. This helps dissect the molecular mechanism of PS externalization. CD9 and Xkr8 have been studied using such assays.
How CRISPR Can Be Used to Study GO:1905782 positive regulation of phosphatidylserine exposure on apoptotic cell surface
Knockout
CRISPR knockout of candidate positive regulators (e.g., Xkr8, CD9) can abolish or reduce PS exposure upon apoptotic stimuli. This validates their role in GO:1905782. For example, Xkr8 knockout impairs PS exposure and affects myoblast differentiation.
Point Mutation
Introducing point mutations in scramblase genes (e.g., Xkr8) can dissect catalytic residues or regulatory phosphorylation sites. This helps determine whether specific residues are required for positive regulation of PS exposure.
Knock-in
Knock-in of tagged versions of regulators (e.g., GFP-Xkr8) allows visualization and immunoprecipitation. This can reveal localization and interaction partners during apoptosis. Such models are valuable for studying the spatiotemporal regulation of PS exposure.
Overexpression
CRISPR activation or lentiviral overexpression of candidate genes can enhance PS exposure, confirming positive regulation. This approach is useful for testing whether a gene is sufficient to increase PS exposure.
How EDITGENE Supports positive regulation of phosphatidylserine exposure on apoptotic cell surface Research
Researchers studying positive regulation of phosphatidylserine exposure on apoptotic cell surface-related genes often need to determine whether a candidate gene is causally involved in enhancing PS externalization. This requires precise genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of phosphatidylserine exposure on apoptotic cell surface research.
Frequently Asked Questions About positive regulation of phosphatidylserine exposure on apoptotic cell surface
What is GO:1905782?
GO:1905782 is a Gene Ontology term for 'positive regulation of phosphatidylserine exposure on apoptotic cell surface'. It describes any process that activates or increases the externalization of phosphatidylserine to the outer leaflet of the plasma membrane during apoptosis.
What genes are involved in positive regulation of phosphatidylserine exposure?
Key genes include Xkr8, which encodes a scramblase, CD9, which modulates calcium-stimulated PS exposure, and P2X7R, which can enhance PS exposure via superoxide. Other apoptosis regulators like Bcl-2 and Bax also correlate with PS exposure.
How is phosphatidylserine exposure detected?
Phosphatidylserine exposure is most commonly detected by Annexin V binding using flow cytometry or fluorescence microscopy. This method can be combined with viability dyes to distinguish apoptotic and necrotic cells.
Why is phosphatidylserine exposure important in apoptosis?
Phosphatidylserine exposure acts as an 'eat-me' signal for phagocytes, ensuring that apoptotic cells are cleared before they release inflammatory contents. It also modulates immune responses, such as dendritic cell maturation.
What diseases are associated with defects in phosphatidylserine exposure?
Defects have been linked to chronic lymphocytic leukemia, where PS exposure correlates with chemotherapy-induced apoptosis, and to autoimmune disorders due to impaired clearance of apoptotic cells.
What is the role of Xkr8 in phosphatidylserine exposure?
Xkr8 is a scramblase that promotes PS exposure during apoptosis and is also involved in myoblast differentiation and survival. Knockout of Xkr8 impairs PS exposure.
How does calcium regulate phosphatidylserine exposure?
Calcium influx is a key trigger for PS exposure. CD9 has been shown to regulate calcium-stimulated PS exposure in Jurkat T lymphocytes. Calcium chelators can block this process.
Can CRISPR be used to study phosphatidylserine exposure?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the regulators of PS exposure. For example, Xkr8 knockout myoblasts show impaired PS exposure.
What is the difference between phosphatidylserine exposure and positive regulation of phosphatidylserine exposure?
Phosphatidylserine exposure is the process itself, while positive regulation refers to the upstream events that enhance or increase the frequency, rate, or extent of that exposure. GO:1905782 specifically covers the positive regulatory aspects.
How does P2X7R influence phosphatidylserine exposure?
P2X7R activation can lead to mitochondrial superoxide generation, which enhances P2X7R-mediated loss of CD62L and may promote PS exposure in T cells. This links purinergic signaling to apoptotic PS externalization.
Conclusion
GO:1905782, positive regulation of phosphatidylserine exposure on apoptotic cell surface, is a critical biological process that ensures efficient clearance of dying cells and modulates immune responses. Key regulators such as Xkr8, CD9, and P2X7R have been identified through experimental studies. Dysregulation of this process is implicated in leukemia and autoimmune conditions. Advances in CRISPR-based models and screening technologies are accelerating the discovery of new regulatory mechanisms. EDITGENE provides comprehensive services to support research in this field, from knockout cell lines to genome-wide screens.
References
- 1. Kim GW et al.. 2017. Xk-related protein 8 regulates myoblast differentiation and survival.. FEBS J 284(21):3575-3588 PMID: 28881496
- 2. Clodi K et al.. 2000. Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes.. Cytometry 40(1):19-25 PMID: 10754513
- 3. Li W et al.. 1998. Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes.. Arch Biochem Biophys 351(1):89-95 PMID: 9500845
- 4. Foster JG et al.. 2013. Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytes.. J Immunol 190(4):1551-9 PMID: 23319734
- 5. Chen X et al.. 2004. Phosphatidylserine regulates the maturation of human dendritic cells.. J Immunol 173(5):2985-94 PMID: 15322157
- 6. Koopman G et al.. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.. Blood 84(5):1415-20 PMID: 8068938
- 7. Bucki R et al.. 2000. Phosphatidylinositol 4,5-bisphosphate domain inducers promote phospholipid transverse redistribution in biological membranes.. Biochemistry 39(19):5838-44 PMID: 10801334
- 8. Homburg CH et al.. 1995. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro.. Blood 85(2):532-40 PMID: 7812008
